The histological co-staining with CD68 confirmed that those cells expressing S100A9 corresponded to myeloid cells (Figure 4F), which play a relevant role in the inflammation and tumorigenesis associated with GBM, as we have recently demonstrated 17, 26-28. The gene discussed is CD68; the disease is glioblastoma.